Literature DB >> 24161039

The role of the complement system in acute kidney injury.

James W McCullough1, Brandon Renner, Joshua M Thurman.   

Abstract

Acute kidney injury is a common and severe clinical problem. Patients who develop acute kidney injury are at increased risk of death despite supportive measures such as hemodialysis. Research in recent years has shown that tissue inflammation is central to the pathogenesis of renal injury, even after nonimmune insults such as ischemia/reperfusion and toxins. Examination of clinical samples and preclinical models has shown that activation of the complement system is a critical cause of acute kidney injury. Furthermore, complement activation within the injured kidney is a proximal trigger of many downstream inflammatory events within the renal parenchyma that exacerbate injury to the kidney. Complement activation also may account for the systemic inflammatory events that contribute to remote organ injury and patient mortality. Complement inhibitory drugs have now entered clinical use and may provide an important new therapeutic approach for patients suffering from, or at high risk of developing, acute kidney injury.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; complement; ischemia/reperfusion

Mesh:

Substances:

Year:  2013        PMID: 24161039      PMCID: PMC3816009          DOI: 10.1016/j.semnephrol.2013.08.005

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  124 in total

Review 1.  Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Authors:  Julien Zuber; Fadi Fakhouri; Lubka T Roumenina; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

2.  Biocompatibility of hemodialysis membranes: a study in healthy subjects.

Authors:  A Gutierrez; A Alvestrand; J Bergström; H Beving; B Lantz; L W Henderson
Journal:  Blood Purif       Date:  1994       Impact factor: 2.614

3.  Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10.

Authors:  N Goes; J Urmson; V Ramassar; P F Halloran
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

4.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.

Authors:  A Sahu; T R Kozel; M K Pangburn
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

5.  Complement activation retards resolution of acute ischemic renal failure in the rat.

Authors:  G Schulman; A Fogo; A Gung; K Badr; R Hakim
Journal:  Kidney Int       Date:  1991-12       Impact factor: 10.612

6.  Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death.

Authors:  J Varis; I Rantala; A Pasternack; H Oksa; M Jäntti; E S Paunu; R Pirhonen
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

7.  Biocompatible membranes in acute renal failure: prospective case-controlled study.

Authors:  H Schiffl; S M Lang; A König; T Strasser; M C Haider; E Held
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

8.  Localization of the complement regulatory proteins in the normal human kidney.

Authors:  S Ichida; Y Yuzawa; H Okada; K Yoshioka; S Matsuo
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

9.  C5a-induced expression of P-selectin in endothelial cells.

Authors:  K E Foreman; A A Vaporciyan; B K Bonish; M L Jones; K J Johnson; M M Glovsky; S M Eddy; P A Ward
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  C3a and C5a promote renal ischemia-reperfusion injury.

Authors:  Qi Peng; Ke Li; Lesley A Smyth; Guolan Xing; Naiyin Wang; Lucy Meader; Bao Lu; Steven H Sacks; Wuding Zhou
Journal:  J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 10.121

View more
  36 in total

Review 1.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

Review 2.  CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Authors:  Peter F Zipfel; Thorsten Wiech; Emma D Stea; Christine Skerka
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

Review 3.  Crescentic acute glomerulonephritis with isolated C3 deposition: a case report and review of literature.

Authors:  Song Mao; Xiaoyan Xuan; Yugen Sha; Sanlong Zhao; Aihua Zhang; Songming Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Immunosuppressive Medications.

Authors:  Alexander C Wiseman
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-13       Impact factor: 8.237

5.  Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients.

Authors:  Edmund Huang; Ashley Vo; Jua Choi; Noriko Ammerman; Kathlyn Lim; Supreet Sethi; Irene Kim; Sanjeev Kumar; Reiad Najjar; Alice Peng; Stanley C Jordan
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-16       Impact factor: 8.237

6.  The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse Plasma.

Authors:  Margarita Semis; Gabriel B Gugiu; Ellen A Bernstein; Kenneth E Bernstein; Markus Kalkum
Journal:  Anal Chem       Date:  2019-05-07       Impact factor: 6.986

7.  A zebrafish model of infection-associated acute kidney injury.

Authors:  Xiaoyan Wen; Liyan Cui; Seth Morrisroe; Donald Maberry; David Emlet; Simon Watkins; Neil A Hukriede; John A Kellum
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-14

8.  Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.

Authors:  John Soltys; Yiting Liu; Alanna Ritchie; Scott Wemlinger; Kristin Schaller; Hannah Schumann; Gregory P Owens; Jeffrey L Bennett
Journal:  J Clin Invest       Date:  2019-04-08       Impact factor: 14.808

Review 9.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 10.  Complement in disease: a defence system turning offensive.

Authors:  Daniel Ricklin; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2016-05-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.